Transcranial Photobiomodulation for Alzheimer's Disease (TRAP-AD)
Transcranial Photobiomodulation for Alzheimer's Disease (TRAP-AD)
Active, not recruiting · NCT04784416 · Registry updated 2025-12-09Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Transcranial Photobiomodulation for Alzheimer's Disease (TRAP-AD) | Alzheimer disease, Cognition Disorders, Cognitive Dysfunction, Mild Cognitive Impairment, brain disorder, central nervous system disorder, cognitive disorder, dementia, nervous system disorder, neurodegenerative disease, psychiatric disorder, tauopathy | Active, not recruiting | Phase 2 | 2025-12-09 | NCT04784416 |
4 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Alzheimer's Association | 36 |
| LiteCure LLC | 1 |
| National Institutes of Health (NIH) | 667 |
| NYU Langone Health | 359 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Massachusetts General Hospital | Boston | United States | 1015 |
| Nathan Kline Institute | Orangeburg | United States | 5 |
| NYU Langone Health | New York | United States | 403 |